Tungkol sa Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor.
Source: Wikipedia
Punong-tanggapan251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Itinatag2018
KatayuanAktibo
Mga patent1 patent
GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019
Mga review
Wala pang review. Nakatrabaho mo na ang Assertio Therapeutics, Inc.? Maging una sa pagbabahagi ng iyong karanasan.
Legal na impormasyon
| Legal na pangalan | Assertio Therapeutics, Inc. |
|---|---|
| LEI | 549300L2A9NTF1JVDP20Tingnan sa GLEIF ↗ |
| Rehistradong address | 251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US |
| Katayuan | Aktibo |
Mga pinagmulan: GLEIF · na-update Oct. 16, 2026
Kontak at mga link
Lokasyon
251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Iyong kumpanya ba ito?
I-claim ang page na ito nang libre upang idagdag ang iyong logo, mga produkto, larawan, at trabaho, at upang sagutin ang mga review.
I-claim ang page na itoSumali sa Heelky upang kumonekta, kumuha, at lumago
Lumikha ng libreng account upang magmensahe sa mga tao, mag-apply sa mga trabaho, at mag-post ng mga misyon.
Sumali ngayon — libre ito